Document is current
Any future updates will be listed below
-
Authors
Goswami, Sangeeta https://orcid.org/0000-0001-9201-4503
Pauken, Kristen E. https://orcid.org/0000-0002-4309-7880
Wang, Linghua https://orcid.org/0000-0001-9380-0266
Sharma, Padmanee https://orcid.org/0000-0003-4658-055X
- License Information
-
More Information
Article History
Received: 8 July 2024
Accepted: 9 October 2024
First Online: 25 November 2024
Competing interests
: P.S. reports consulting fees from Achelois, Affini-T, Akoya Biosciences, Apricity, AsherBio, BioAtla, Candel Therapeutics, Catalio, C-Reveal, Dragonfly, Earli, Enable Medicine, Glympse, Henlius/Hengenix, Hummingbird, ImaginAb, Intervenn Biosciences, LAVA Therapeutics, Lytix, Marker, Oncolytics, Osteologic, PBM Capital, Phenomic AI, Polaris Pharma, Spotlight, Trained Therapeutix, Two Bear Capital and Xilis; and ownership of stock in Adaptive Bio, BioNtech, JSL Health, Sporos and Time Bioventures. K.E.P. reports an advising relationship with Guardant Health that may result in advising fees. S.G. and L.W. have no competing interests.
